Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid
Clinical trial NCT05263505 · TERMINATED
Trial details
- NCT number
- NCT05263505
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-21
- Primary completion
- 2023-09-11
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.